XML 125 R28.htm IDEA: XBRL DOCUMENT v3.24.4
SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Equity [Abstract]    
SCHEDULE OF STOCK OPTION

A summary of the stock option activity under the Company’s incentive plan for the nine months ended September 30, 2024 is presented below:

 

   Number of Shares   Weighted Average Exercise Price   Weighted Average Grant Date Fair Value   Weighted Average Remaining Contractual Term (years)   Aggregate Intrinsic Value 
Outstanding at December 31, 2023   2,022   $857.55   $1,158.30    3.4   $ 
Granted      $   $          
Forfeited   (484)  $590.25   $810.30          
Outstanding at September 30, 2024   1,538   $941.55   $1,267.65    2.6   $ 
                          
Exercisable at September 30, 2024   1,477   $979.50   $1,319.70    2.2   $ 

A summary of the stock option activity under the Company’s incentive plan for the years ended December 31, 2023 and 2022 is presented below:

 

   Number of Shares   Weighted Average Exercise Price   Weighted Average Grant Date Fair Value   Weighted Average Remaining Contractual Term (years)   Aggregate Intrinsic Value 
Outstanding at January 1, 2022   1,589   $1,185   $1,552.50    5.3   $34,333 
Granted   1,700   $46.05   $38.70    

 

   $ 
Forfeited   (67)  $2,625   $2,107.50        $ 
Outstanding at December 31, 2022   3,222   $555.75   $672.30    4.1   $ 
Granted      $   $          
Forfeited   (1,200)  $46.05   $38.70          
Outstanding at December 31, 2023   2,022   $857.55   $1,158.30    3.4   $ 
                          
Exercisable at December 31, 2023   1,712   $966.75   $1,330.80    2.9   $ 
SCHEDULE OF STOCK OPTION ASSUMPTION  

Options granted during the years ended December 31, 2022 were valued using the Black Scholes model with the following assumptions:

 

   December 31, 2022 
Term (years)   5.5 
Stock price  $46.05 
Exercise price  $46.05 
Dividend yield    
Expected volatility   112.0%
Risk free interest rate   3.9%
SCHEDULE OF RESTRICTED STOCK UNITS AND AWARDS ACTIVITY

The Company’s activity in restricted stock units was as follows for the nine months ended September 30, 2024:

 

   Number of shares   Weighted average fair value 
Non-vested at December 31, 2023   9,366   $434.55 
Granted   16,767   $12.75 
Forfeited   (650)  $43.05 
Vested   (2,042)  $333.30 
Non-vested at September 30, 2024   23,441   $152.55 

The Company’s activity in restricted stock units was as follows for the year ended December 31, 2023:

 

   Number of shares   Weighted average
fair value
 
Non-vested at January 1, 2022   4,135   $1,890 
Granted   2,497   $502.50 
Forfeited   (1,785)  $1,194.60 
Vested   (576)  $1,958.25 
Non-vested at December 31, 2022   4,271   $1,388.55 
Granted   12,167   $40.95 
Forfeited   (2,896)  $385.80 
Vested   (4,176)  $297.00 
Non-vested at December 31, 2023   9,366   $434.55 
SCHEDULE OF STOCK-BASED COMPENSATION FOR RESTRICTED STOCK UNITS

The following table summarizes the Company’s recognition of stock-based compensation for restricted stock units for the following periods:

 

Stock-based compensation expense for RSUs:  2024   2023   2024   2023 
   Three Months Ended September   Nine Months Ended September 
Stock-based compensation expense for RSUs:  2024   2023   2024   2023 
General and administrative  $162,042   $101,607   $476,513   $946,851 
Research and development   207,158    226,646    620,057    691,514 
Total  $369,200   $328,253   $1,096,570   $1,638,365 

The following table summarizes the Company’s recognition of stock-based compensation for restricted stock units for the following periods:

 

   2023   2022 
   Year ended December 31, 
   2023   2022 
Stock-based compensation expense for RSUs:          
General and administrative  $1,085,791   $1,389,359 
Research and development   908,294    1,026,907 
Total  $1,994,085   $2,416,266 
SCHEDULE OF WARRANTS OUTSTANDING

The following table summarizes information about shares issuable under warrants outstanding at September 30, 2024:

 

   Warrant shares outstanding   Weighted average exercise price   Weighted average remaining life   Intrinsic value 
Outstanding at December 31, 2023   186,614   $176.85    4.6   $ 
Expired   (39)   2,400.00       $ 
Exercised   (130,267)   20.55       $ 
Outstanding at September 30, 2024   56,308   $536.70    3.0   $ 
                     
Exercisable at September 30, 2024   56,308   $536.70    3.0   $ 

The following table summarizes information about shares issuable under warrants outstanding at December 31, 2023 and 2022:

 

   Warrant shares outstanding   Weighted average exercise price   Weighted average remaining life   Intrinsic value 
Outstanding at January 1, 2022   13,031   $1,965    3.4   $801,024 
Issued   81,834   $154.65        $ 
Exercised   (51,167)  $        $ 
Exchanged for common stock      $        $ 
Outstanding at December 31, 2022   43,698   $875.40    3.6   $5,514 
Issued   154,088   $20.55       $ 
Exercised   (8,134)  $20.55        $ 
Forfeited   (3,038)  $1,672.50        $ 
Outstanding at December 31, 2023   186,614   $176.85    4.6   $ 
                     
Exercisable at December 31, 2023   186,614   $176.85    4.6   $ 
SCHEDULE OF INVESTMENT OPTIONS

The following table summarizes information about investment options outstanding at September 30, 2024:

 

   Investment options outstanding   Weighted average exercise price   Weighted average remaining life   Intrinsic value 
Outstanding at December 31, 2023   4,667   $150.00    4.1   $ 
Outstanding at September 30, 2024   4,667   $150.00    2.9   $ 
                     
Exercisable at September 30, 2024   4,667   $150.00    2.9   $ 

The following table summarizes information about investment options outstanding at December 31, 2023 and 2022:

 

   Investment options outstanding   Weighted average exercise price   Weighted average remaining life   Intrinsic value 
Outstanding at January 1, 2022      $        —   $     
Issued   71,334   $118.95         
Outstanding at December 31, 2022   71,334   $118.95    5.1   $ 
Exercised   (66,667)  $20.55         
Outstanding at December 31, 2023   4,667   $150.00    4.1   $ 
                     
Exercisable at December 31, 2023   4,667   $150.00    4.1   $ 
SCHEDULE OF BLACK SCHOLES VALUATION MODEL FOR VALUATION OF WARRANTS  

The Company established the initial fair value of its equity classified Inducement Warrants at the date of issuance on December 28, 2023. The Company used a Black Scholes valuation model in order to determine their value. The key inputs into the Black Scholes valuation model for the valuation of the warrants are below:

 

   Roth and Inducement Warrants 
   December 28, 2023 
Term (years)   5.0 
Stock price  $23.40 
Exercise price  $20.55 
Dividend yield   %
Expected volatility   92.0%
Risk free interest rate   3.80%
      
Number of warrants   154,088 
Value (per share)  $17.40